Key result
Phytochemicals targeting PPARs, LXRs, and PCSK9 show promising lipid-lowering and anti-atherosclerotic effects in CVD.
Answers are grounded in this paper and cite their sources.
Phytochemicals targeting key regulators of cholesterol homeostasis and inflammation could constitute important tools for cardiovascular disease management.
A large body of evidence has shown that modulation of the nuclear receptors peroxisome proliferator-activated receptors (PPARs), the liver X receptors (LXRs), the proprotein convertase subtilisin/kexin type 9 (PCSK9) and inflammatory processes by natural compounds has hypolipidemic and anti-atherosclerotic effects. These beneficial outcomes are certainly related to the crucial function of these targets in maintaining cholesterol homeostasis and regulating systemic inflammation. Currently, the therapeutic scenario for cardiovascular diseases (CVD) offers a plethora of widely validated and functional pharmacological treatments to improve the health status of patients. However, patients are increasingly sceptical of pharmacological treatments which are often associated with moderate to severe side effects. The aim of our review is to provide a collection of the most recent scientific evidence on the most common phytochemicals, used for centuries in the Mediterranean diet and traditional chinese medicine that act on these key regulators of cholesterol homeostasis and systemic inflammation, which could constitute important tools for CVD management.
No takes yet. Share an insight, caveat, or question.
Palumbo et al. (2024) conducted a review in Cardiovascular diseases. Natural compounds and phytochemicals was evaluated. Natural compounds and phytochemicals targeting PPARs, LXRs, and PCSK9 may offer beneficial hypolipidemic and anti-atherosclerotic effects for cardiovascular disease management.
Synapse has enriched 10 related papers. Consider them for comparative context: